Basic Information
| RNALocate ID: | RLID-D:11000496 |
| RNA Symbol: | hsa-miR-501-5p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-501-5p |
| RNA ID: | miRBase:MIMAT0002872 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002354 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01002355 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:11003111 | Exosome | Brain tissue | 23382797 |
| RLID:11003112 | Exosome | Plasma | 23663360 |
| RLID:11003113 | Microvesicle | Liver resident stem cells | 20668554 |
| RLID:11003114 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11001299 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-501-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-55510 |
| MNDR | hsa-miR-501-5p | Ovarian clear cell carcinoma | MNDR-E-MI-55511 |
| MNDR | hsa-miR-501-5p | Lymphoma | MNDR-E-MI-55512 |
| MNDR | hsa-miR-501-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-55513 |
| MNDR | hsa-miR-501-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-55514 |
| MNDR | hsa-miR-501-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-55515 |
| MNDR | hsa-miR-501-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-55516 |
| MNDR | hsa-miR-501-5p | Her2-receptor positive breast cancer | MNDR-E-MI-55517 |
| MNDR | hsa-miR-501-5p | Breast cancer luminal | MNDR-E-MI-55518 |
| MNDR | hsa-miR-501-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-55519 |
| MNDR | hsa-miR-501-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-55520 |
| MNDR | hsa-miR-501-5p | Dermatomyositis | MNDR-E-MI-55521 |
| MNDR | hsa-miR-501-5p | Prostate cancer | MNDR-E-MI-55522 |
| MNDR | hsa-miR-501-5p | Gastric cancer | MNDR-E-MI-55523 |
| MNDR | hsa-miR-501-5p | Alzheimer disease | MNDR-E-MI-55524 |
| MNDR | hsa-miR-501-5p | Dysautonomia familial | MNDR-E-MI-55525 |
| MNDR | hsa-miR-501-5p | Leukemia | MNDR-E-MI-55526 |
| MNDR | hsa-miR-501-5p | Lung cancer | MNDR-E-MI-55527 |
| MNDR | hsa-miR-501-5p | Parkinson disease | MNDR-E-MI-55528 |
| MNDR | hsa-miR-501-5p | Breast cancer | MNDR-E-MI-55529 |
| MNDR | hsa-miR-501-5p | Pituitary neoplasms | MNDR-E-MI-55530 |
| MNDR | hsa-miR-501-5p | Pancreatic cancer | MNDR-E-MI-55531 |
| MNDR | hsa-miR-501-5p | Melanoma | MNDR-E-MI-55532 |
| MNDR | hsa-miR-501-5p | Nephroblastoma | MNDR-E-MI-55533 |
| MNDR | hsa-miR-501-5p | Colon adenocarcinoma | MNDR-E-MI-55534 |
| MNDR | hsa-miR-501-5p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-55535 |
| MNDR | hsa-miR-501-5p | Familial ovarian cancer | MNDR-E-MI-55536 |
| MNDR | hsa-miR-501-5p | Prostate adenocarcinoma | MNDR-E-MI-55537 |
| MNDR | hsa-miR-501-5p | Carcinoma ductal breast | MNDR-E-MI-55538 |
| MNDR | hsa-miR-501-5p | Glioblastoma | MNDR-E-MI-55539 |
| MNDR | hsa-miR-501-5p | Glioma | MNDR-E-MI-55540 |
| MNDR | hsa-miR-501-5p | Nemaline myopathy | MNDR-E-MI-55541 |
| MNDR | hsa-miR-501-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-55542 |
| MNDR | hsa-miR-501-5p | Epilepsy temporal lobe | MNDR-E-MI-55543 |
| MNDR | hsa-miR-501-5p | Osteosarcoma | MNDR-E-MI-55544 |
| MNDR | hsa-miR-501-5p | Gastric adenocarcinoma | MNDR-E-MI-55545 |
| MNDR | hsa-miR-501-5p | Pituitary adenoma | MNDR-E-MI-55546 |
| MNDR | hsa-miR-501-5p | Lung squamous cell carcinoma | MNDR-E-MI-55547 |
| MNDR | hsa-miR-501-5p | Non-small cell lung adenocarcinoma | MNDR-E-MI-55548 |
| MNDR | hsa-miR-501-5p | Lung adenocarcinoma | MNDR-E-MI-55549 |
| MNDR | hsa-miR-501-5p | Ovarian carcinoma | MNDR-E-MI-55550 |
| MNDR | hsa-miR-501-5p | Pancreatic adenocarcinoma | MNDR-E-MI-55551 |
| MNDR | hsa-miR-501-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-55552 |
| MNDR | hsa-miR-501-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-55553 |
| MNDR | hsa-miR-501-5p | Clear cell renal cell carcinoma | MNDR-E-MI-55554 |
| MNDR | hsa-miR-501-5p | Cholangiocarcinoma | MNDR-E-MI-55555 |
| MNDR | hsa-miR-501-5p | Esophageal cancer | MNDR-E-MI-55556 |
| MNDR | hsa-miR-501-5p | Lung small cell carcinoma | MNDR-E-MI-55557 |
| MNDR | hsa-miR-501-5p | Stomach carcinoma | MNDR-E-MI-55558 |
| MNDR | hsa-miR-501-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-55559 |
| MNDR | hsa-miR-501-5p | T acute lymphoblastic leukemia | MNDR-E-MI-55560 |
| MNDR | hsa-miR-501-5p | Acute t cell leukemia | MNDR-E-MI-55561 |
| MNDR | hsa-miR-501-5p | Breast invasive carcinoma | MNDR-E-MI-55562 |
| MNDR | hsa-miR-501-5p | Hepatocellular carcinoma | MNDR-E-MI-55563 |
| MNDR | hsa-miR-501-5p | Familiar ovarian carcinoma | MNDR-E-MI-55564 |
| MNDR | hsa-miR-501-5p | Retinoblastoma | MNDR-E-MI-55565 |
| MNDR | hsa-miR-501-5p | Barrett's adenocarcinoma | MNDR-E-MI-55566 |
| MNDR | hsa-miR-501-5p | Tonsil cancer | MNDR-E-MI-55567 |
| MNDR | hsa-miR-501-5p | Colorectal cancer | MNDR-E-MI-55568 |
| MNDR | hsa-miR-501-5p | Multiple myeloma | MNDR-E-MI-55569 |
| MNDR | hsa-miR-501-5p | Prostatic neoplasms | MNDR-E-MI-55570 |
| MNDR | hsa-miR-501-5p | Polymyositis | MNDR-E-MI-55571 |
| MNDR | hsa-miR-501-5p | Stroke lacunar | MNDR-E-MI-55572 |
| MNDR | hsa-miR-501-5p | Barrett's carcinogenesis | MNDR-E-MI-55573 |
| MNDR | hsa-miR-501-5p | Breast cancer her3+ negative | MNDR-E-MI-55574 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | DKK1 | Homo sapiens | RR00442071 |
TOP